Delivery Order SPE2DB20D2104-SPE2DB22FR63N
Award Date
1/26/22
Potential Completion Date
1/27/22
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with a ceiling value of $1,604.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,555,086,379 capsules of the pharmaceutical drug Ramipril 2.5 mg. The contract is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
This federal contract award is for the delivery of Ramipril 2.5 mg capsules, a cardiovascular medication, to the Defense Logistics Agency (DLA). The contract, valued at $1,894.88, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 30, 2024, with a completion date of January 31, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,647.77, is for the delivery of 4,558,957,998 units of Ramipril 10 mg capsules, which are a cardiovascular medication. The contract is a Firm Fixed Price Delivery Order that has an ultimate completion date of November 2, 2022. It is not designated with any set-aside requirements, indicating...
This federal contract award, valued at $2,321.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,560,539,267 units of Ramipril 10 mg capsules, a cardiovascular medication, to support military healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,558,877,954 Ramipril 5 mg capsules to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $2,358.42, has an ultimate completion date of October 26, 2022. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,938.28 firm-fixed-price delivery order is for the supply of 4,565,908,863 units of the pharmaceutical drug Ramipril 2.5 mg capsules. The award has a completion date of September 24, 2024 and is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award is for the delivery of Ramipril 2.5 mg capsules in quantities of 500 capsules per bottle. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on January 31, 2024. The contract has a ceiling value of $2,353.45 and a completion date of February 1, 2024. This is a delivery order contract with a firm fixed-price pricing type. The contract does not have a set-aside designation, indicating it was...
This federal contract award (SPE2DB20D3103|SPE2DB21FP9Q9) was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4554485446 - Ramipril 5 mg capsules in 500-count quantities. The contract has a ceiling value of $4,319.43 and an ultimate completion date of August 20, 2021. The award was made on a firm fixed-price basis with no set-aside designation, indicating open competition....
This federal contract award is for the delivery of Ramipril 10 mg capsules to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $2,268.98 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, on January 10, 2022, with a completion date of January 11, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,229.57 firm fixed price delivery order is for the supply of 4554485288 units of Ramipril 10 mg capsules. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC serves as...